SHPH Shuttle Pharmaceuticals Holdings, Inc.
Company Analysis
Latest News
Shuttle Pharmaceuticals Issues Common Stock, Warrants, and Pre-Funded Warrants
Shuttle Pharmaceuticals Holdings, Inc. announced the issuance of various unregistered equity securities following stockholder approval obtained at a Special...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 15, 2026
Shuttle Pharmaceuticals is expected to report zero revenue and a projected EPS loss of -$0.43 for the second quarter, while its $3.53 stock price currently...
Shuttle Pharmaceuticals Shareholders Approve Name Change to United Compute Inc. and Merger-Related Share Issuances
Shuttle Pharmaceuticals (SHPH) announced that its stockholders have approved all proposals at a Special Meeting held on September 9, 2026. Key approvals...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 08, 2026
Consensus revenue for the second quarter is estimated at $0.0 million as Shuttle Pharmaceuticals remains a pre-revenue entity, while formal analyst EPS...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on September 01, 2026
Consensus revenue is expected to be $0.00 with a projected loss per share of -$0.43, while the current stock price of $3.54 sits slightly below the modest...
Receives Nasdaq Non-Compliance Notice for Delayed Quarterly Report Filing
Shuttle Pharmaceuticals received a notification from Nasdaq on August 28, 2026, indicating non-compliance with listing requirements due to the delayed filing...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 25, 2026
Shuttle Pharmaceuticals is expected to report a Q2 2026 loss of approximately $0.45 per share on $0.00 in revenue, with the current stock price of $3.76...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 18, 2026
Shuttle Pharmaceuticals is expected to report second-quarter 2026 revenue of $0.00 and a consensus EPS of $0.00, with the stock trading at $4.07 against an...
Shuttle Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Shuttle Pharmaceuticals is expected to report zero revenue and a consensus EPS loss of $4.30 for Q2 2026, with the stock trading at $4.36 relative to a...
🔴 Shuttle Pharmaceuticals is trading 8.2% down today on insider selling and United Dogecoin merger dilution concerns
Shuttle Pharmaceuticals is trading 8.2% down at $3.01 after a string of insider sales and growing dilution concerns tied to its United Dogecoin merger. -...
🔴 Shuttle Pharmaceuticals is trading 5.2% down today on insider selling and post-merger dilution concerns
Shuttle Pharmaceuticals is trading at $3.11 (-5.18%) in pre-market, continuing its downward trajectory following Thursday’s sharp selloff. • The decline is...
🔴 Shuttle Pharmaceuticals is trading 10.6% down
Shuttle Pharmaceuticals is trading at $3.19, down 10.6% from a comparison close of $3.57 during regular trading. This is a price-action follow-up, so a...
🔴 Shuttle Pharmaceuticals is trading 8.7% down today following post-rally volatility
Shuttle Pharmaceuticals is trading 8.7% down at $3.26 today as the stock experiences post-rally volatility following a significant gain in the previous...
🔴 Shuttle Pharmaceuticals is trading 10.9% down
Shuttle Pharmaceuticals is trading at $3.18, down 10.9% from a comparison close of $3.57 during pre-market. This is a price-action follow-up, so a separate...
🔴 Shuttle Pharmaceuticals is trading 9.1% down today as it pulls back from a previous 9.5% gain with no fresh catalysts
Shuttle Pharmaceuticals is trading at $3.24 (-9.11%) in pre-market, pulling back after a significant gain in the previous session. • The move follows a 9.51%...
🔴 SHPH is trading 5.6% down today after a sharp regular-session gain
SHPH is trading at $3.37 (5.6% down) in after-hours, pulling back from a sharp 9.5% regular-session gain to $3.57. • No fresh company-specific news, earnings,...
🟢 SHPH extends move to 6.4% up
SHPH is trading at $3.47, up 6.4% versus the comparison close of $3.26 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SHPH is trading 5.2% up today as it pivots from drug development to Dogecoin mining
SHPH is trading 5.2% up at $3.43 following the company’s formal pivot from drug development to cryptocurrency mining. • The strategic shift follows the...
Shuttle Pharmaceuticals Ditches Drug Research to Mine Dogecoin — Bold Reinvention or Red Flag for Shareholders?
Shares of Shuttle Pharmaceuticals surged 19.5% to $3.90 on July 8 after the micro-cap biotech formalized its transformation into a cryptocurrency mining...
🟢 SHPH is trading 19.5% up today as its United Dogecoin subsidiary details plans for new data centers
• Shuttle Pharmaceutical Holdings' United Dogecoin subsidiary announced plans to build proprietary data center and power assets in Idaho and Alberta. • The...